1. Home
  2. RNXT vs AHT Comparison

RNXT vs AHT Comparison

Compare RNXT & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • AHT
  • Stock Information
  • Founded
  • RNXT 2012
  • AHT 2003
  • Country
  • RNXT United States
  • AHT United States
  • Employees
  • RNXT N/A
  • AHT N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • AHT Real Estate Investment Trusts
  • Sector
  • RNXT Health Care
  • AHT Real Estate
  • Exchange
  • RNXT Nasdaq
  • AHT Nasdaq
  • Market Cap
  • RNXT 44.6M
  • AHT 37.2M
  • IPO Year
  • RNXT 2021
  • AHT 2003
  • Fundamental
  • Price
  • RNXT $1.14
  • AHT $6.30
  • Analyst Decision
  • RNXT Strong Buy
  • AHT
  • Analyst Count
  • RNXT 2
  • AHT 0
  • Target Price
  • RNXT $7.25
  • AHT N/A
  • AVG Volume (30 Days)
  • RNXT 107.8K
  • AHT 23.9K
  • Earning Date
  • RNXT 08-14-2025
  • AHT 07-30-2025
  • Dividend Yield
  • RNXT N/A
  • AHT N/A
  • EPS Growth
  • RNXT N/A
  • AHT N/A
  • EPS
  • RNXT N/A
  • AHT N/A
  • Revenue
  • RNXT $240,000.00
  • AHT $1,129,071,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • AHT N/A
  • Revenue Next Year
  • RNXT $301.89
  • AHT N/A
  • P/E Ratio
  • RNXT N/A
  • AHT N/A
  • Revenue Growth
  • RNXT N/A
  • AHT N/A
  • 52 Week Low
  • RNXT $0.75
  • AHT $5.20
  • 52 Week High
  • RNXT $1.69
  • AHT $11.99
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 33.69
  • AHT 45.32
  • Support Level
  • RNXT $1.23
  • AHT $6.46
  • Resistance Level
  • RNXT $1.28
  • AHT $6.47
  • Average True Range (ATR)
  • RNXT 0.06
  • AHT 0.24
  • MACD
  • RNXT -0.01
  • AHT -0.05
  • Stochastic Oscillator
  • RNXT 15.00
  • AHT 13.70

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: